HK2 and arthritic joint disease: Given HK2 selective overexpression in inflamed RA synovium, its small role in T cells, and its expression in a very limited number of adult tissues, HK2 is an attractive selective target for arthritis therapy that is safer than global glucose metabolism inhibition (19).